Breast cancer patients who undergo a mastectomy should receive subsequent radiation treatment if their cancer has spread to four or more nearby lymph nodes. However, according to a new study, only 65 percent of these women are getting the recommended postmastectomy radiation therapy (PMRT).



A set of guidelines developed to help standardized lung cancer screening would have generated considerably fewer false-positives than the National Lung Screening Trial produced, according to a new retrospective study.



Sanovas Inc. announced that one of its clinical advisers is warning that the United States healthcare system faces a shortage of therapeutic resources as Medicare coverage of lung cancer screening for at-risk beneficiaries goes into effect. Lung cancer is the leading cause of cancer death and the second-leading cause of all deaths in the United States.



A pioneering clinical trial is testing whether focusing high-frequency sound waves onto the surface of bone where cancer has spread can burn away the source of pain.


In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, M.D., Ph.D., discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought. 

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February 1, 2015 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). 

The American Society for Radiation Oncology (ASTRO) commends the February 5, 2015, decision by the Centers for Medicare and Medicaid Services (CMS) to provide coverage for annual lung cancer screening via low-dose CT screening for those at highest-risk for lung cancer.

Patients with soft tissue sarcoma of an extremity treated with preoperative image-guided radiotherapy (IGRT) experience significantly fewer long-term treatment side effects compared with a historical control group treated with preoperative, non-image-guided radiation therapy (RT), according to results of the RTOG 0630 trial published online in the Journal of Clinical Oncology. 

Subscribe Now